{
    "2018-12-28": [
        [
            {
                "time": "",
                "orginal_text": "年度盘点：2018年国内药企发展关键词",
                "features": {
                    "keywords": [
                        "年度盘点",
                        "国内药企",
                        "发展关键词"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "医疗保健：按疾病诊断相关分组付费试点正式出台",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "疾病诊断",
                        "分组付费",
                        "试点出台"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "医疗保健：坚守低估值与确定性 荐7股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "低估值",
                        "确定性",
                        "荐股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "午评：沪股通净流入13.55亿 深股通净流入1.84亿",
                "features": {
                    "keywords": [
                        "午评",
                        "沪股通",
                        "深股通",
                        "净流入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物2019年投资策略：创新才是硬道理",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "创新"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "公告隐现重大利好 周五8只个股有望突破大涨",
                "features": {
                    "keywords": [
                        "公告",
                        "重大利好",
                        "个股",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物行业:控费改革进程中关注结构性投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "控费改革",
                        "结构性投资机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}